Introduction
Clearly if doubt exists about the efficacy of a particular treatment or the superiority of one treatment over another, it is desirable to find an answer. Solutions to scientific problems have their foundations in the deduction of first principles and these ideas are supported by observations and then confirmed by experimentation. In the case of medicine the most reliable experiment is a randomised controlled clinical trial.
Before a clinical trial can be considered ethical both the procedural and substantive ethics must be acceptable. Procedural ethics in a controlled clinical trial largely revolves around the question of consent and this is central to the question of how to perform a trial, not whether a trial is ethical in itself (1) .
Substantive ethics questions whether the trial
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should be conducted at all. It is not enough to rely totally on consent. In some cases it might be wrong to offer patients entry into a trial -to tempt them to make a choice which most people would argue is strongly against their interests. If this were not so, then the function of the ethics committee would simply be to ensure that fact disclosure was obtained before a patient agreed to enter a trial. But The responses to three of the scenarios is shown in figure 1 . The human trial most likely to be tolerated was the comparison of headache analgesics (scenario A). In this trial, the median level of equipoise was 67 Figure 1 per The argument we wish to present here, is not that the substantive ethics trials should be subjected to routine ethometric studies although we do think that these might be illuminating in certain (particularly contentious) cases. Our intention is to demonstrate that the concept of collective ethometrics, while an important contribution to the debate, is not an all or none phenomenon and can (at least theoretically) be quantified. Thus, Freeman, while contributing greatly to the debate by explaining the difference between individual and collective equipoise and while explaining the importance of the latter, has not resolved this issue to the degree suggested in the New EnglandJ7ournal ofMedicine article (6) . This underlines a still more important facet of the ethics of randomised trials which is that they are subject to gradualism not absolutism. The ethical undesirability of a trial grows as, for example, the strength of certainty that a particular treatment is superior increases. If this view is accepted, then the substantive ethics of trials is not unlike that which can be advanced for termination of pregnancy where the medical and ethical undesirability of the procedure can be perceived to rise as gestational age increases. The point in this gradual increment where a procedure becomes substantially unethical can be submitted to ethometric evaluation. It should also be noted that the limits of equipoise vary with the subject under discussion, although by a smaller amount than we had anticipated. This suggests that our results may be influenced by an element of mid-range anchoring and this, together with various framing effects, explains why we do not think that our results are accurate and binding. They indicate an order of magnitude, rather than a precise cut-off limit. It is nevertheless clear that the majority of our subjects are less likely to tolerate trials involving issues with which the subject can personally identify or those which cover emotive issues. This might partly be related to aesthetics and an emotional, unsubstantiated 'gut feeling' but it is also related to the perceived quality of the future life of those who have been selected for the trial (neonates are more aesthetically attractive and have a greater life expectancy than old people, and beagles have a greater perceived 'quality' of life than rats).
It should be noted that these limits of equipoise obtained by consumer trade-off surveys cannot be clearly translated into the probability ( 
Conclusions
Collective equipoise is an important (albeit not overriding) consideration in the substantive ethics of randomised trials. In general, when more than 3/4 of experts favour one treatment over another, more than half of people will feel that a human trial is substantively unethical. Our subjects seem to tolerate slightly more relaxed levels of equipoise as the subject of research becomes less emotive. They demonstrate speciesism, preferring experiments on rats to beagles and beagles to humans. The substantive ethics of randomised trials depend on collective and individual beliefs about the superiority of various treatments. Utilitarians will usually favour randomised trials until equipoise is very strongly unbalanced, because more people outside the trial stand to lose from acceptance of an inferior treatment than do people inside the trial who are allocated to an inferior arm. Therefore, unless the lifespan of a treatment is likely to be very short, the greatest good comes to the greatest number by doing a large number of trials to a high level of precision. However, if overriding importance is given to the individual patient who cannot be asked to make any sacrifice for the common good, then trials are only ethical in the face of complete collective (and perhaps even individual) equipoise. We cannot get away from the truth that, rare instances of complete equipoise apart, trials represent a trade-off between maximising our obligations to an individual patient and those to future patients. Our study shows that most subjects accept a small trade-off of the individual good for the collective good. Appendix I SCENARIO A Doctors are uncertain as to which treatment is best for headaches. Two pain-killing drugs (A and B) have been extensively tested and are known to be safe. SCENARIO B At the moment death can be prevented in half of those patients with leukaemia by prescribing the established drug. An alternative drug is available but doctors are uncertain as to which of these two treatments is the most effective. If either drug fails the patient will surely die. There is no possibility of trying the other treatment because by that time it will be too late. SCENARIO C (i) Some patients are at risk of developing pneumonia following an operation. Doctors are uncertain as to which of two antibiotics (A and B) to use to decrease the risk. Only one of these drugs may be used because they interact. Ifthe antibiotic fails then the sick patient may develop pneumonia and this could be fatal. The trial is to be performed in geriatric patients.
SCENARIO C (ii)
Doctors also want to perform the same trial in newborn babies recovering from an operation. Assume that pneumonia is equally dangerous in geriatric patients and babies. 
